Structure and Anti-HIV Activity of Betulinic Acid Analogues
- 22 June 2018
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 38 (3) , 387-397
Abstract
Firstly discovered in 1980s, human immunodeficiency virus (HIV) continues to affect more and more people. However, there is no effective drug available for the therapy of HIV infection. Betulinic acid existing in various medicinal herbs and fruits exhibits multiple biological effects, especially its outstanding anti-HIV activity, which has drawn the attentions of many pharmacists. Among the derivatives of betulinic acid, some compounds exhibited inhibitory activities at the nanomolar concentration, and have entered phase II clinical trials. This paper summarizes the current investigations on the anti-HIV activity of betulinic acid analogues, and provides valuable data for subsequent researches.Keywords
This publication has 42 references indexed in Scilit:
- A convergent synthesis of novel alkyne–azide cycloaddition congeners of betulinic acid as potent cytotoxic agentSteroids, 2017
- C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitorsBioorganic & Medicinal Chemistry, 2016
- Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation InhibitorsAntimicrobial Agents and Chemotherapy, 2016
- Anti-HIV Drug Discovery and Development: Current Innovations and Future TrendsJournal of Medicinal Chemistry, 2015
- Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation InhibitorsThe Open Medicinal Chemistry Journal, 2014
- Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl esterBioorganic & Medicinal Chemistry Letters, 2009
- Impact of Natural Products on Developing New Anti-Cancer AgentsChemical Reviews, 2009
- Semisynthetic Derivatives of Epothilones2009
- Multi-target therapeutics: when the whole is greater than the sum of the partsDrug Discovery Today, 2007
- Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564Virology, 2004